Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0J9ZF
|
||||
| Former ID |
DNC013019
|
||||
| Drug Name |
4-benzyl-2-methylphthalazin-1(2H)-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528062] | ||
| Formula |
C16H14N2O
|
||||
| Canonical SMILES |
CN1C(=O)C2=CC=CC=C2C(=N1)CC3=CC=CC=C3
|
||||
| InChI |
1S/C16H14N2O/c1-18-16(19)14-10-6-5-9-13(14)15(17-18)11-12-7-3-2-4-8-12/h2-10H,11H2,1H3
|
||||
| InChIKey |
KUTSOIMAOFABLX-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Alpha-1D adrenergic receptor | Target Info | Inhibitor | [528062] | |
| Alpha-1A adrenergic receptor | Target Info | Inhibitor | [528062] | ||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| PANTHER Pathway | Alpha adrenergic receptor signaling pathway | ||||
| References | |||||